Author Claim Review

 Quick Explanation Copied

 Long Explanation

Publication Record and Impact

OpenAlex attributes to Amarendranath Choudhury (ORCID 0000-0002-7042-8139) 28 works, 584 citations, and an h-index of 13. Output is concentrated in 2013–2023 with a 2017 peak (7 works, 198 citations that year), while 2021–2024 output is sparse and citations are declining — a late-to-mid career profile with limited recent activity. His most-cited paper is a 2013 review on silymarin's neuroprotective mechanisms (103 citations) Silymarin neuroprotection review, followed by an empirical PLoS ONE study showing cholesterol accelerates dopaminergic loss in MPTP mice (92 citations) Cholesterol-MPTP mouse study and a hypothesis paper proposing endogenous cholesterol as a Parkinson's contributor (61 citations) Cholesterol-Parkinson.

Positionality and Independence

Citation-weight analysis shows he is predominantly a middle author on his most-cited work; senior positions belong to Borah (last author on the cholesterol series) or Mohanakumar. First/last-authored papers — a 2018 Neuropsychiatry review (39 citations) and a 2017 morin phytocomponent review (32 citations) — are lower-impact, some in journals of questionable standing (e.g., the DOAJ-listed and OMICS-style Neuropsychiatry outlets) First-author neurochemicals review. This pattern suggests a skilled collaborator in a productive lab rather than an independent group leader.

Breadth vs. Focus

His portfolio spans neurochemistry, diabetes/beta-cell biology Cholesterol beta-cell review, rhizosphere microbiology Tea rhizosphere bacteria study, and deep-learning engineering (45-citation drowsiness detection conference paper) Deep learning drowsiness detection paper. This breadth, while showing adaptability, dilutes depth; there is no continuous first-author experimental line. Blind spots: the MPTP mouse model's limited translation to human Parkinson's, narrative-review-heavy output, and several closed/low-tier venues limit verifiability.

Review Collaborator Borah Evaluate Cholesterol-PD Hypothesis

 BGPT Author Review

Scientific Quality

H-index 13 with 584 citations is respectable for a regional Indian university researcher, but the impact is concentrated in middle-authored reviews and lab-led MPTP papers; first-authored works appear in lower-quality venues with modest citations. Substantial cross-disciplinary switching and sparse recent output reduce evidence of sustained independent scientific leadership.

Communication Quality

Reviews are reportedly comprehensive (one with 266 references), indicating solid synthesis ability, but several appear in journals with weak editorial standards, and abstracts suggest conventional rather than pedagogically distinguished writing.

Author Novelty

The cholesterol-Parkinson's hypothesis was somewhat novel around 2015–2017 and stimulated citations, but it builds on established oxidative-stress/lipid frameworks; most other outputs are reviews of known phytocompounds or conventional applied work.

Scientific Rigor

The PLoS ONE MPTP study involved controlled animal work in a reputable journal, indicating sound empirical practice; however, reliance on narrative reviews, low reference counts in some articles, and publications in questionable journals weaken overall rigor and reproducibility visibility.